Stock comparison
Molina Healthcare
Summit Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MOH
Molina Healthcare
Market cap
$9.64B
Sector
Healthcare
SMMT
Summit Therapeutics
Market cap
$13.08B
Sector
Healthcare
Overall winner
Molina Healthcare MOH
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MOH | SMMT | Winner |
|---|---|---|---|
| Warren Buffett | 23F | 12F | MOH |
| Benjamin Graham | 71B | 40D | MOH |
| Philip Fisher |
Side-by-side metrics
| Metric | MOH | SMMT |
|---|---|---|
| Market cap | $9.64B | $13.08B |
| P/E (TTM) | 50.2x | - |
| EV/EBIT | 10.6x | - |
| ROIC (TTM) | 5.27% | -2.48% |
| Gross margin | 9.59% | 0.0% |
| Net margin | 0.42% | 0.0% |
| Revenue CAGR 5y | 13.09% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MOH leads on
- ROIC (TTM)5.27%vs -2.48%+102%
- Gross margin9.59%vs 0.0%+100%
- Net margin0.42%vs 0.0%+100%
SMMT leads on
More like SMMT
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.